Literature DB >> 12370291

Gamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element.

Takeshi Kuwata1, Celine Gongora, Yuka Kanno, Kazuyasu Sakaguchi, Tomohiko Tamura, Tomohiko Kanno, Venkatesha Basrur, Robert Martinez, Ettore Appella, Todd Golub, Keiko Ozato.   

Abstract

ICSBP (IRF-8) is a transcription factor of the IRF family expressed only in the immune system. It is induced in macrophages by gamma interferon (IFN-gamma) and contributes to macrophage functions. By interacting with Ets family protein PU.1, ICSBP binds to the IRF/Ets composite element and stimulates transcription. ICSBP binds to another DNA element, the IFN-stimulated response element (ISRE), a common target of the IRF family. Limited knowledge as to how ICSBP and other IRF proteins regulate ISRE-dependent transcription in IFN-gamma-activated macrophages is available. By mass-spectrometric analysis of ISRE-bound proteins in macrophages, we identified TEL, another Ets member, as a factor recruited to the element in an IFN-gamma-dependent manner. In vitro analysis with recombinant proteins indicated that this recruitment is due to a direct interaction between ICSBP and TEL, which is enhanced by the presence of ISRE. Significantly, the interaction with TEL in turn resulted in the recruitment of the histone deacetytase HDAC3 to the ISRE, causing increased repression of IFN-gamma-mediated reporter activity through the ISRE. This repression may provide a negative-feedback mechanism operating after the initial transcriptional activation by IFN-gamma. By associating with two different Ets family proteins, ICSBP exerts a dual function in IFN-gamma-dependent gene regulation in an immune system-specific manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370291      PMCID: PMC135656          DOI: 10.1128/MCB.22.21.7439-7448.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  TEL is a sequence-specific transcriptional repressor.

Authors:  R G Lopez; C Carron; C Oury; P Gardellin; O Bernard; J Ghysdael
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

2.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

3.  Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.

Authors:  A L Brass; E Kehrli; C F Eisenbeis; U Storb; H Singh
Journal:  Genes Dev       Date:  1996-09-15       Impact factor: 11.361

Review 4.  The TEL gene and human leukemia.

Authors:  T R Golub; T McLean; K Stegmaier; M Carroll; M Tomasson; D G Gilliland
Journal:  Biochim Biophys Acta       Date:  1996-08-08

5.  PU.1 can participate in an active enhancer complex without its transcriptional activation domain.

Authors:  J M Pongubala; M L Atchison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

6.  The TEL gene products: nuclear phosphoproteins with DNA binding properties.

Authors:  H Poirel; C Oury; C Carron; E Duprez; Y Laabi; A Tsapis; S P Romana; M Mauchauffe; M Le Coniat; R Berger; J Ghysdael; O A Bernard
Journal:  Oncogene       Date:  1997-01-23       Impact factor: 9.867

7.  Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro.

Authors:  I M Wang; J C Blanco; S Y Tsai; M J Tsai; K Ozato
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

8.  Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.

Authors:  T Holtschke; J Löhler; Y Kanno; T Fehr; N Giese; F Rosenbauer; J Lou; K P Knobeloch; L Gabriele; J F Waring; M F Bachmann; R M Zinkernagel; H C Morse; K Ozato; I Horak
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

9.  A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.

Authors:  C Jousset; C Carron; A Boureux; C T Quang; C Oury; I Dusanter-Fourt; M Charon; J Levin; O Bernard; J Ghysdael
Journal:  EMBO J       Date:  1997-01-02       Impact factor: 11.598

10.  Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element.

Authors:  C Bovolenta; J Lou; Y Kanno; B K Park; A M Thornton; J E Coligan; M Schubert; K Ozato
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more
  27 in total

1.  The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8.

Authors:  Prafullakumar Tailor; Tomohiko Tamura; Hee Jeong Kong; Toru Kubota; Mayumi Kubota; Paola Borghi; Lucia Gabriele; Keiko Ozato
Journal:  Immunity       Date:  2007-08-16       Impact factor: 31.745

Review 2.  IRF8 regulates myeloid and B lymphoid lineage diversification.

Authors:  Hongsheng Wang; Herbert C Morse
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

3.  Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.

Authors:  Weiqi Huang; Wei Zhou; Gurveen Saberwal; Iwona Konieczna; Elizabeth Horvath; Efstratios Katsoulidis; Leonidas C Platanias; Elizabeth A Eklund
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

4.  The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).

Authors:  Weiqi Huang; Liping Hu; Ling Bei; Elizabeth Hjort; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

5.  Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.

Authors:  Coline Gaillard; Sangeetha Surianarayanan; Trevor Bentley; Matthew R Warr; Briana Fitch; Huimin Geng; Emmanuelle Passegué; Hugues de Thé; Scott C Kogan
Journal:  Blood Adv       Date:  2018-10-09

6.  Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages.

Authors:  Leopoldo Laricchia-Robbio; Tomohiko Tamura; Tatiana Karpova; Brian L Sprague; James G McNally; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-23       Impact factor: 11.205

7.  Discovery and validation of information theory-based transcription factor and cofactor binding site motifs.

Authors:  Ruipeng Lu; Eliseos J Mucaki; Peter K Rogan
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

8.  Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression.

Authors:  Kun Zhang; Dong-Wen Lv; Renfeng Li
Journal:  Virology       Date:  2019-11-11       Impact factor: 3.616

9.  Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR.

Authors:  Jeongheon Yoon; Xianxum Feng; Yong-Soo Kim; Dong-Mi Shin; Katerina Hatzi; Hongsheng Wang; Herbert C Morse
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

10.  IRF8 regulates B-cell lineage specification, commitment, and differentiation.

Authors:  Hongsheng Wang; Chang Hoon Lee; Chenfeng Qi; Prafullakumar Tailor; Jianxun Feng; Sadia Abbasi; Toru Atsumi; Herbert C Morse
Journal:  Blood       Date:  2008-09-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.